Turkish Journal of Medical Sciences
Volume 40

Number 1

Article 10

1-1-2010

Comparison of remifentanil, alfentanil, and fentanil coadministered with propofol to facilitate laryngeal mask insertion
ALİ SIZLAN
UĞUR GÖKTAŞ
CEYDA ÖZHAN
MEHMET ÖZGÜR ÖZHAN
MEHMET EMİN ORHAN

See next page for additional authors

Follow this and additional works at: https://journals.tubitak.gov.tr/medical
Part of the Medical Sciences Commons

Recommended Citation
SIZLAN, ALİ; GÖKTAŞ, UĞUR; ÖZHAN, CEYDA; ÖZHAN, MEHMET ÖZGÜR; ORHAN, MEHMET EMİN; and
KURT, ERCAN (2010) "Comparison of remifentanil, alfentanil, and fentanil co-administered with propofol to
facilitate laryngeal mask insertion," Turkish Journal of Medical Sciences: Vol. 40: No. 1, Article 10.
https://doi.org/10.3906/sag-0901-21
Available at: https://journals.tubitak.gov.tr/medical/vol40/iss1/10

This Article is brought to you for free and open access by TÜBİTAK Academic Journals. It has been accepted for
inclusion in Turkish Journal of Medical Sciences by an authorized editor of TÜBİTAK Academic Journals. For more
information, please contact academic.publications@tubitak.gov.tr.

Comparison of remifentanil, alfentanil, and fentanil co-administered with propofol
to facilitate laryngeal mask insertion
Authors
ALİ SIZLAN, UĞUR GÖKTAŞ, CEYDA ÖZHAN, MEHMET ÖZGÜR ÖZHAN, MEHMET EMİN ORHAN, and
ERCAN KURT

This article is available in Turkish Journal of Medical Sciences: https://journals.tubitak.gov.tr/medical/vol40/iss1/10

Original Article

Turk J Med Sci
2010; 40 (1): 63-70
© TÜBİTAK
E-mail: medsci@tubitak.gov.tr
doi:10.3906/sag-0901-21

Comparison of remifentanil, alfentanil, and fentanil
co-administered with propofol to facilitate laryngeal mask
insertion
Ali SIZLAN1, Uğur GÖKTAŞ2, Ceyda ÖZHAN2 , Mehmet Özgür ÖZHAN1, Mehmet Emin ORHAN1,
Ercan KURT1

Aim: To compare the efficacy of different doses of fentanil, remifentanil, and alfentanil co-administered with propofol
in patients undergoing minor surgery.
Materials and methods: This double-blind, multi-centered, placebo-controlled study was conducted in 2 medical centers.
One hundred forty-one ASA class I and II adult patients aged 18-65 years were included in the study. Patients received
i.v. 1 μg kg–1 fentanil (group F, n = 33), 10 μg kg–1 alfentanil (group A, n = 33), 0.5 μg kg–1 remifentanil (group R, n = 36),
or saline (control group, n = 39) co-administered with propofol 2.5 mg kg–1 without additives over 30 s. An LMA was
inserted 90 s later. Conditions for the LMA insertion were assessed. The number of attempts, airway quality, and
hemodynamic changes were recorded.
Results: There were no significant differences in the demographic data among the groups. The LMA was more easily
placed in the remifentanil group compared with the other groups . All first attempts for the LMA insertion were successful
in the remifentanil group. When the opiates groups were compared with the control group, easier insertion rates were
detected in all the opiate groups. LMA insertion was easiest in the remifentanil group, followed by the alfentanil, fentanil,
and control groups, in that order. Heart rates and blood pressures were reduced in all groups, but no treatment was
required.
Conclusion: Opiates co-administered with propofol improved the LMA insertion conditions compared to propofol
alone. Out of the opiates, remifentanil had the highest success rate.
Key words: Remifentanil, alfentanil, fentanil, propofol, laryngeal mask airway

Larengeal mask yerleştirmede propofole eklenen remifentanil, alfentanil ve
fentanilin etkilerinin karşılaştırılması
Amaç: Minör cerrahideki hastalarda propofole eklenen farklı dozlardaki remifentanil, fentanil ve alfentanilin etkilerini
birbirleriyle ve plasebo kontrollü olarak karşılaştırmayı amaçladık.
Yöntem ve gereç: Bu çalışma çift kör, çok merkezli (GATA-Ankara ve 100. Yıl Üniversitesi-Van), plasebo kontrollü olarak
yapıldı. Etik komite onayından sonra ASA I ve II sınıfı, yetişkin, 18-65 yaş arasında çalışmayı kabul eden 141 hasta
çalışmaya alındı. İv. olarak hastalardan grup F’ye (n = 33) 1 μg kg–1 fentanil, grup A’ya (n = 33) 10 μg kg–1 alfentanil, grup
R’ye (n = 36) 0,5 μg kg–1 remifentanil ve kontrol grubu C’ye (n = 39) salin, 2,5 mg kg–1 katkısız propofole ilave olarak 30
sn. üzerindeki sürede verildi. 90 sn. sonra LMA yerleştirildi. LMA yerleştirme kolaylığı değerlendirildi. Girişim sayısı,
hava yolu sağlama kolaylığı ve hemodinamik değişiklikler kaydedildi.
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Bulgular: Hastaların demografik verilerinde farklılık yoktu. Diğer gruplarla karşılaştırıldığında remifentanil grubunda
LMA daha kolay yerleştirildi. Remifentanil grubunda tüm LMA’ lar birinci seferde yerleştirilebildi. Opiat grupları kontrol
grupları ile karşılaştırıldığında tümünde kontrol gruplarına göre daha kolay yerleştirme oranları tespit edildi. Grupların
daha kolay LMA yerleştirebilme sıralaması remifentanil> alfentanil> fentanil> kontrol grubu olarak bulundu. Kalp hızı
ve kan basınçları tüm gruplarda azaldı fakat tedaviye ihtiyaç göstermedi.
Sonuç: Bu çalışma göstermiştir ki propofole eklenen opiatlar LMA yerleştirme koşullarını yalnız kullanılan propofole göre
iyileştirmiştir. Opiatlardan en yüksek başarı oranını remifentanil sağlamıştır.
Anahtar sözcükler: Remifentanil, alfentanil, fentanil, propofol, larengeal mask airway

Introduction

Materials and methods

Laryngeal mask airway (LMA) is one of the
most popular airway devices in anesthetic
practice. The increased speed and reliability of
placement, improved hemodynamic stability at
induction, reduced anesthetic requirements for
airway tolerance, lower frequency of coughing
during emergence, and lower incidence of sore
throat are the main advantages of LMA over the
tracheal tube (1). LMA insertion is not always
straightforward and requires supression of the
upper airway reflexes and some degree of skill.
LMA may be inserted with propofol alone, and
the dose of propofol required for the smooth
insertion of the LMA has been reported to range
from 2.0 to 2.5 mg kg-1 (2). Higher doses of
propofol may cause hemodynamic disturbances.
In spite of this, propofol alone may be insufficient
to blunt airway responses and not prevent
coughing, gagging, breath holding, and patient
movement. A number of adjuncts, such as
lidocain, low doses of muscle relaxant and opioids
have been used to improve the LMA insertion
conditions (3-6). Of these, opiates are the most
commonly used. Different doses of fentanil,
alfentanil, and remifentanil have been proven for
this issue and, in general, adjuncts increase the
successful insertion rates to over 90% (7). In this
prospective, multi-centered, placebo-controlled
study, we aimed to compare the LMA insertion
conditions and hemodynamic changes with
fentanil, alfentanil. and remifentanil added as a
bolus to propofol and propofol administered
alone during induction of anesthesia.

The study was conducted in 2 medical centers in
Turkey: Gülhane Military Medical Faculty and
Yüzüncü Yıl University Medical Faculty. Local Ethical
Committee approval for the study was obtained from
both centers and written informed consent from all
patients. One hundred forty-one ASA class I and II
adult patients aged 18-65 years were included in this
randomized double-blind study. They were all
scheduled for minor surgery in which spontaneous
ventilation using a LMA was the most appropriate
technique. The patients with an anticipated difficult
airway, as determined by a Mallampati score of 3 or
more, were excluded.

64

All patients were fasted for over 6 h and no
premedication was given. One of 4 identical 10 mL
-1
syringes containing fentanil 1 μg kg , alfentanil 10 μg
-1
-1
kg , remifentanil 0.5 μg kg (made up to 10 mL with
normal saline), or 10 mL saline was selected as the
study drug. The content of the syringe was decoded
after the study. Standard anesthetic monitoring was
applied and the patients were pre-oxygenated for 3
min. The study drug, followed by propofol 2.5 mg kg
1
, without additives, was injected intravenously over
30 s and flushed with normal saline. The patient was
ventilated with oxygen and 90 s later a lubricated
LMA, size 3 for females and size 4 and 5 for males,
was inserted by one of the authors, who was blinded
to the study group, using the technique described by
Brain (8).
The study investigator assessed insertion
conditions using a 6-variable, 3-point score that
graded mouth opening, ease of the LMA insertion,
and the patient response, i.e. swallowing, gagging–

A. SIZLAN, U. GÖKTAŞ, C. ÖZHAN, M. Ö. ÖZHAN, M. E. ORHAN, E. KURT

couching, head/limb movement, and laryngospasm.
The percentage of the patients exhibiting each
response was calculated. The position of the LMA was
checked by observing respiratory movements and
chest expansion. Any malpositioned or nonfunctioning LMA was removed, the patient given a
further dose of propofol 1 mg kg-1, and, 60 s later,
reinsertion attempted. The number of attempts for the
successful insertion was noted.
Once the LMA had been successfully inserted, the
patient was intermittently ventilated via the LMA to
maintain the arterial oxygen saturation above 95%
and the end-tidal carbon dioxide concentration
between 35 and 45 mmHg until resumption of
spontaneous respiration. Anesthesia was then
maintained with 2% sevoflurane and 50% nitrous
oxide in oxygen.
The patient’s blood pressure and heart rate were
recorded before induction of anesthesia, 1 min after
induction, and again 1 min after successful LMA
insertion.
Statistical analysis was performed using SPSS 10.0
for Windows. The number and percentage of the
patients with each score for all 6 variables were
calculated. Insertion scores were then compared using
the chi-square test for trends. Blood pressure and
heart rate changes during the insertion were
compared using analysis of variance for repeated
measures, with Bonferroni correction. Data are
presented as mean (SD or range) and P < 0.05 was
considered significant.

Results
Data were collected from 141 patients, aged 18-65
years. The 4 patient groups were similar with respect
to age, gender, ASA physical status, weight, and height
(Table 1).
Mouth opening was ideal (full) in all the patients
in the remifentanil group compared to the others
(100% in the remifentanil group, 94% in the alfentanil
group, 78% in the fentanil group, and 71% in the
control group; P < 0.05). Median score of mouth
opening was lowest in the remifentanil group, while it
was highest in the control group (remifentanil <
alfentanil < fentanil < control; P < 0.05, Table 2).
The LMA insertion was graded as easy in all the
patients in the remifentanil group. The ratio of easy
LMA insertion was similar between the fentanil and
alfentanil groups (84% vs. 87%; P > 0.05) and higher
than the control group (71%, P < 0.05) (Figure).
The LMA insertion resulted in swallowing,
gagging–coughing, and head–limb movement
responses in all study groups. Out of them, the
remifentanil group had the lowest score, while the
control group had the highest (P < 0.05). Scores of the
alfentanil group were lower than those of the fentanil
group (P < 0.05). Laryngospasm occurred in all
groups except the remifentanil group, but this
difference was not statistically significant (P > 0.05).
When comparing the total score of the LMA insertion
conditions, the total score of the remifentanil group
was lower than that of the other groups (remifentanil
< alfentanil < fentanil < control; P < 0.05).

Table 1. Patient demographics and ASA status for the study groups. No significant difference between
the groups.

Gender (f/m)
ASA grade (I/II)
Age (years)
Weight (kg)
Height (cm)

Fentanil
n = 33

Alfentanil
n = 33

Remifentanil
n = 36

Control
n = 39

P
value

11: 22
27 : 6
31.54 ± 11.29
72.51 ± 12.55
169.84 ± 7.29

8 : 25
24 : 9
34.45 ± 14.11
73.39 ± 12.14
170.78 ± 8.27

10 : 26
26 : 10
33.88 ± 16.12
76.86 ± 14.17
170.30 ± 8.83

12 : 27
35 : 4
31.07 ± 9.74
73. 84 ± 11.59
169.97 ± 18.18

0.862
0.130
0.106
0.866
0.506

Results presented as mean (SD) or ratios. P < 0.05 considered statistically significant.
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Table 2. The LMA insertion conditions of the study groups. Assessments used 6 variables/3 grade score.
Assessment

Grades

Fentanil

Alfentanil

Remifentanil

Control

P value

Mouth opening

full (1) / partial (2) / nil (3)
Median Score

26 / 7 / 0
1.2 ± 0.4

31 / 2 / 0
1.06 ± 0.2

36 / 0 / 0
1.0 ± 0

28 / 10 / 1
1.30 ± 0.5

0.01

Overall ease

easy (1) / difficult (2) / impossible (3)
Median Score

28 / 5 / 0
1.15 ± 0.3

29 / 4 / 0
1.12 ± 0.3

36 / 0 / 0
1.0 ± 0

25 / 12 / 2
1.41 ± 0.5

0.00

Swallowing

nil (1) / slight (2) / gross (3)
Median Score

27 / 4 / 2
1.27 ± 0.5

29 / 2 / 2
1.18 ± 0.5

34 / 2 / 0
1.12 ± 0.3

20 / 12 / 7
1.66 ± 0.7

0.01

Gagging & coughing

nil (1) / slight (2) / gross (3)
Median Score

28 / 3 / 2
1.24 ± 0.5

29 / 2 / 2
1.18 ± 0.5

32 / 3 / 1
1.13 ± 0.4

25 / 7 / 7
1.53 ± 0.7

0.025

Head & limb
movement

nil (1) / slight (2) / gross (3)
Median Score

21 / 8 / 4
1.48 ± 0.7

26 / 4 / 3
1.30 ± 0.6

31 / 4 / 1
1.16 ± 0.4

12 / 17 / 10
1.97 ± 0.77

0.00

Laryngospasm

nil (1) / partial (2) / total (3)
Median Score

31 / 1 / 1
1.09 ± 0.3

32 / 0 / 1
1.06 ± 0.3

36 / 0 / 0
1.0 ± 0

34 / 2 / 3
1.20 ± 0.5

0. 14

7.39 ± 2.2

6.93 ± 2.0

6.27 ± 0.94

9.1 ± 2.8

0.00

Total Score of the LMA insertion conditions

100

easy

80
60
40
20
0

Fentanil

Alfentanil

Remifentanil

control

Figure. Comparison of ease of the LMA insertion between the
groups. Values are expressed as percentages (%).

All first attempts for the LMA insertion were
successful in the remifentanil group. Three patients
in the alfentanil group and 5 patients in the fentanil
group required a second attempt, which was lower
than the control group (14 patients; P < 0.05). The
LMA insertion was impossible in 1 patient in the
fentanil group and 5 patients in the control group and
these patients were intubated with ETT (Table 3).
Heart rates, and systolic and diastolic blood
pressures decreased in all groups following induction
compared with the baseline (P < 0.05; Table 4). The
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decreases in blood pressure were greater in the
patients receiving remifentanil and heart rate
decreases were greater in the alfentanil group (P <
0.05); they were well within clinically acceptable
limits. After the insertion of the LMA, blood pressures
were elevated in all groups except the remifentanil
group. The difference was not statistically significant
(P > 0.05). After the insertion of the LMA, heart rates
remained stable in all groups.
Discussion
We showed that propofol (2.5 mg kg-1) coadministered with alfentanil (10 μg kg-1), fentanil (1
μg kg-1), or remifentanil (0.5 μg kg-1), compared with
propofol alone (2.5 mg kg-1) reduced the number of
the patients who responded adversely to the LMA
insertion from 35% to 7.8%.
We used a 6-variable/3-grade scoring system
described by Chui et al. and further modified by Hui
et al. to assess the LMA insertion conditions (Table 2)
(6,9,10). The studies to facilitate the LMA insertion
with opiates added to propofol can be divided into 2
main categories. The first category included studies
comparing different doses of same opiate co-
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Table 3. Number of attempts and endotracheal intubation.
Fentanil

Alfentanil

Remifentanil

Control

P value

Second attempt of the LMA insertion

5 (15%)

3 (9%)

0 (0%)

14 (35%)

0.022

Endotracheal Intubation

1 (3%)

0 (0%)

0 (0%)

5 (12.8%)

0.031

Table 4. Hemodynamic changes.
Fentanil

Alfentanil

Remifentanil

Control

P value

Preinduction

SAP
DAP
MAP
HR

128 ± 14
74 ± 12
94 ± 10
83 ± 13

132 ± 20
76 ± 10
96 ± 13
80 ± 12

133 ± 19
72 ± 11
94 ± 14
77 ± 18

130 ± 16
76 ± 9
93 ± 11
79 ± 13

0.653
0.378
0.812
0.383

Postinduction

SAP
DAP
MAP
HR

100 ± 14
56 ± 9
73 ± 9
76 ± 13

100 ± 18
56 ± 14
71 ± 14
70 ± 11

101 ± 15
53 ± 9
72 ± 11
73 ± 16

105 ± 17
60 ± 13
76 ± 13
76 ± 16

0.468
0.089
0.395
0.219

1 min after the LMA insertion

SAP
DAP
MAP
HR

105 ± 15
59 ± 13
77 ± 14
72 ± 15

107 ± 24
61 ± 14
78 ± 16
69 ± 12

100 ± 15
53 ± 11
73 ± 12
70 ± 15

116 ± 22
68 ± 15
86 ± 17
74 ± 12

0.010
0.00
0.03
0.405

Values are expressed as mean ± SD. P < 0.05 considered statistically significant. SAP = Systolic Arterial Pressure (mmHg), DAP = Diastolic
Arterial pressure (mmHg), MAP = Mean Arterial Pressure (mmHg), HR = Heart Rate (beats/min)

administered with propofol to find out the standard
dose of the opiate for the LMA insertion. Kodaka et al.
-1
compared 0.5, 1, and 2 μg kg fentanil coadministered with propofol using target-controlled
infusion to determine the effective concentration for
50% of the attempts (EC 50 LMA) to secure the LMA
insertion and reported that a fentanil dose of 0.5 μg
-1
kg is sufficient to decrease EC 50 LMA of propofol
with minimum respiratory depression (11). Wong et
al. compared 4 different doses of fentanil (0.5, 1.0, 1.5,
-1
and 2.0 μg kg ) co-administered with propofol 2.5 mg
-1
-1
kg and reported a standard dose of that 1.0 μg kg
fentanil provided optimal conditions in 65% of the
cases and stated that a 90 s period for the LMA
insertion may have been insufficient for fentanil to
reach its peak effect (12).
-1

In our study, 1 μg kg fentanil enabled easy
insertion of the LMA in 28 out of 33 patients (85%).
The difference between our study and Wong’s study
may be attributed to their patients being mainly

ethnic Chinese with smaller jaws. Yu et al. compared
-1
5, 10, 15, and 20 μg kg doses of alfentanil coadministered with 2.5 mg kg-1 propofol to determine
an optimum dose of alfentanil to facilitate LMA
insertion and found that the optimum dose for
alfentanil was 10 μg kg-1 and the duration of apnea
increased with increasing dosage of alfentanil to over
5 min (13). The laryngeal mask insertion was
unsuccessful only in 1 out of 60 alfentanil patients
(98%). In contrast, Ang et al. compared 2 different
doses of alfentanil (5 and 10 μg kg-1) added to
propofol 2.5 mg kg-1 and concluded that 5 μg kg-1
prior to propofol provides excellent conditions for the
insertion of laryngeal mask with minimal adverse
hemodynamic changes (14). The success rate during
the first attempt was similar in the 5 and 10 μg kg-1
alfentanil groups (96% and 94%, respectively).
However, the use of alfentanil 10 μg kg-1 with propofol
led to a significant decrease in the mean arterial
pressure and the heart rate.
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In another study, Lee et al. compared 2 different
doses of remifentanil (0.25 μg kg-1 and 0.5 μg kg-1)
added to 2.5 mg kg-1 propofol or 2.5 mg kg-1 propofol
administered alone and found that 0.25 μg kg-1
remifentanil provides excellent conditions for the
insertion of the LMA with minimal hemodynamic
disturbances (15). Furthermore, 82.5% of the patients
in the 0.25 μg kg-1 remifentanil group and 85.0% of the
patients in the 0.5 μg kg-1 remifentanil group had
excellent insertion conditions as compared with the
control group, 32.5%.
In a similar study, Yazicioglu et al. found that both
doses of remifentanil combined with propofol
provided good and excellent conditions for the LMA
insertion with minimal hemodynamic disturbances
and propofol given alone is not a good agent for the
LMA insertion (16). Ease of the LMA insertion was
assessed as grade 1 in 100% of the patients in the 0.5
μg kg-1 remifentanil group, 65% in the 0.25 μg kg-1
remifentanil group, and 30% in the saline group.
Undesirable responses following the LMA insertion
were observed in 54% of the patients in the control
group. Kwak et al. reported that the bolus dose of
remifentanil to facilitate the LMA insertion with
propofol 2.5 mg kg-1 at which there was a 50%
probability of successful laryngeal mask insertion
(ED50) during induction with 2.5 mg kg -1 propofol
was 0.56 (0.07) μg kg-1 in children without a
neuromuscular blocking agent (17). Grewal and
Samsoon reported that remifentanil 0.3 μg kg-1
combined with propofol target-controlled infusion
compared to propofol alone facilitates the LMA
insertion with minimal adverse hemodynamic
changes (18). Remifentanil significantly increased the
ease and success of laryngeal mask insertion, with
grade 1 (no coughing/gagging) conditions observed
in 29 (68%) of the remifentanil group and 21 (49%)
of the control group (P < 0.01). The doses of
remifentanil and propofol used were not associated
with any significant cardiorespiratory instability.
The studies in the second category were conducted
to compare the effects of different opiates coadministered with propofol on the LMA insertion
conditions. Hui et al. compared the insertion
conditions following co-administration of 10 μg kg-1
alfentanil with 1 μg kg-1 fentanil added to 2.5 mg kg-1
propofol and reported that co-administration of
68

alfentanil-propofol provided better insertion
conditions than fentanil-propofol, although apnea
was prolonged by 72 s (10). Mouth opening and ease
of the insertion were not improved with alfentanil coadministration. Alfentanil-propofol reduced the
incidence of swallowing, gagging, movement, and
laryngospasm (P < 0.05), with 29% (alfentanil)
compared to 45% (fentanil) of the patients responding
(P = 0.05) to the LMA insertion. Qattan et al.
compared the insertion conditions following coadministration of 0.5 μg kg-1 remifentanil with 5 μg
kg-1 alfentanil added to 2.5 mg kg-1 propofol and found
excellent conditions in 85% of the patients in the
remifentanil group and in 80% of the patients in the
alfentanil group compared to 55% in the control
group (19). Mean arterial pressure decreased
significantly in all groups and the mean heart rate was
significantly lower in the remifentanil and alfentanil
groups compared to baseline values, which were well
within clinically acceptable limits. They concluded
that both drugs provided similar conditions for the
LMA insertion. In our study, we found that
remifentanil is superior when compared to alfentanil
by means of mouth opening, ease of the LMA
insertion, and head and limb movement (100% vs.
93%, 100% vs. 88%, and 86% vs. 78%, P < 0.05).
In the present study, the categories of “head–limb
movement” and “swallowing” had the highest number
of non-ideal patients (36% and 25%, respectively).
These results conflict with the study by Hui et al.,
which reported that mouth opening and the insertion
of the LMA were non-ideal in 47%-49% and 32%-42%
of their patients (10). This difference is surprising
because they did not have a control group, which was
greatly responsible for the unfavorable conditions. In
our study, the majority of these non-ideal patients
were included (69%). When the control group is
excluded, the ratio of the non-ideal patients is reduced
to 23.5%. In our study, ease of the LMA insertion and
mouth opening were assessed as grade 1 in 100% of
the patients in the remifentanil group. This result is
supported by the study by Yazicioglu et al. (16). Once
again, these 2 categories had lowest number of nonideal patients with the category of “laryngospasm” in
all study groups (14%, 16%, and 5.6%, respectively). In
addition, the major role of propofol for the LMA
insertion should not be forgotten. Propofol continues
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to be the drug of choice by means of hypnotic for the
LMA insertion. In a recent study, Uzun et al.
compared propofol (2.5 mg kg-1) with etomidate (0.3
mg kg-1) co-administered with a remifentanil bolus of
0.5 μg kg-1, followed by a 2-min remifentanil infusion
of 0.05 μg kg-1 per min (20). Only 13 LMAs of 25 were
inserted at the first attempt in the etomidateremifentanil group compared with 23 of 25 in the
propofol-remifentanil group. Gagging, chest rigidity,
and myoclonus occurred significantly more
frequently in the etomidate-remifentanil group.
The decreases in heart rates and blood pressure
following induction were statistically significant, but
these hemodynamic changes did not require any
treatment. No patient in the study groups developed
significant hypotension, bradycardia, or desaturation.
Many authors reported that drug doses in our study
resulted in clinically insignificant hemodynamic
disturbances (14-19). Despite co-administration of

opiates, in 8 patients (7.8%) a second attempt of the
LMA insertion was required and one of them (fentanil
group; 1%) was intubated. However; all the first
attempts were successful in the remifentanil group
compared to the other opiates groups (P < 0.05). Once
again, these results are lower than the control group.
The success rate of the LMA insertion in our study is
higher than that of the study of Hui et al. when the
control group of our study is excluded (1% vs. 3.5%)
(10).
In conclusion, co-administration of remifentanilpropofol provides better insertion conditions than
alfentanil-propofol, fentanil–propofol, and propofol
alone.
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